Company Announcements - Jihua Group's existing product system does not involve brain-computer interface related fields [1] - Prit's plan to invest 1 billion yuan to build a plastic modification materials headquarters and R&D manufacturing base in South China [1][2] - Lian De Equipment won a contract worth 157 million yuan for BOE's 8.6 generation AMOLED production line project [1][2] - Jiadu Technology plans to issue shares (H-shares) overseas and list on the Hong Kong Stock Exchange [1][2] - Longdi Group intends to acquire no more than 20.1667% equity in Jujia Technology [1][4] - New Zhonggang plans to repurchase shares worth 40 million to 80 million yuan [1][4] - Xiaogoods City expects a net profit increase of 12.57% to 17.40% in the first half of the year [1][4] - Sinopec Capital plans to reduce its holdings by no more than 3.5256 million shares in Haizheng Materials through block trading [1][4] - Lihua Co., Ltd. intends to reduce its holdings by no more than 3.00% [1][4] - Zhimin Da plans to raise no more than 213 million yuan through a private placement [1][5] - Xiangtong Co. plans to issue corporate bonds not exceeding 4 billion yuan [1][5] Performance Forecasts - Hanyu Pharmaceutical expects a half-year profit of 142 million to 162 million yuan, turning a profit compared to the previous year [4] - Taotao Automotive anticipates a net profit increase of 70.34% to 97.81% in the first half of the year [4] - Weichai Heavy Machinery expects a net profit increase of 40% to 60% in the first half of the year [4] Shareholding Changes - Lihua Co., Ltd.'s actual controller Cheng Lili and his concerted actors plan to reduce their holdings by no more than 3.00% [4] - He Shi Eye Hospital's Advanced Manufacturing Fund plans to reduce its holdings by no more than 2% [4] - Haitan Ruisheng's shareholder He Lin and his concerted actors plan to reduce their holdings by no more than 2.9463% [4] - Sinopec Capital plans to reduce its holdings by no more than 3.5256 million shares in Haizheng Materials [4] Other Announcements - Zhimin Da plans to raise no more than 213 million yuan through a private placement [5] - Yuyuan Co. plans to issue corporate bonds not exceeding 40 billion yuan [5] - Jinhongshun has terminated the planning of a major asset restructuring [5]

Market Overview - The Hong Kong stock market is experiencing a decline, with the Hang Seng Index dropping by 0.87% as large funds adjust their positions, particularly in the financial sector [1] - In contrast, the A-share market is witnessing a collective rise, attributed to the China Securities Regulatory Commission's new logo, interpreted by investors as a sign of a "triple win" for the stock market, listed companies, and investors [1] Trade Relations and Tariffs - Concerns over tariffs remain prevalent in the Hong Kong market, with the U.S. government indicating that trade negotiations may extend beyond the initial deadline set by the Trump administration [2] - The U.S. Treasury Secretary stated that negotiations with multiple trade partners could continue until September, reflecting a lack of significant progress in talks with major partners [2] - China's firm stance against sacrificing its interests in trade negotiations has influenced other countries, such as India, to adopt a tougher approach [2] Inflation and Economic Indicators - The U.S. core PCE price index for May increased by 2.68% year-on-year, surpassing expectations and reaching its highest level since February 2025 [3] - The inflation outlook suggests that the Federal Reserve is unlikely to lower interest rates in the upcoming meetings, with expectations of inflation peaking in July or August [3] - In China, industrial profits for large enterprises declined by 1.1% year-on-year from January to May, with a significant drop of 9.1% in May alone [3] Legislative Developments - The U.S. Senate passed the "Big Beautiful Bill" with a narrow margin, which could lead to increased government debt to stimulate economic growth [4] - The bill's passage may have mixed implications, as the U.S. national debt exceeds $36 trillion, raising concerns about sustainability [4] - The bill includes compromises that may benefit sectors such as healthcare and renewable energy, positively impacting related stocks [4] Stock Performance and New Listings - Newly listed stocks like Chow Tai Fook (06168) have seen significant gains, with a 25% increase on the day, nearly doubling in value over three days [5] - Old Town Gold (06181) also benefited from the strong performance of its new Singapore store, with a nearly 15% rise in stock price [5] - Cloud Wisdom (09678), the first AGI stock in Hong Kong, surged over 44% on its debut, driven by strong revenue growth projections [6] Sector Focus - The military industry is gaining attention due to reports of Iran negotiating the purchase of Chinese fighter jets and abandoning U.S. GPS in favor of China's BeiDou navigation system [8] - The photovoltaic glass sector is addressing supply-demand imbalances, with plans for a 30% production cut starting in July to stabilize prices [9] - Companies like Eastman Chemical (00189) are expected to benefit from increased demand for refrigerants, with a significant rise in profitability anticipated [10][11]

Group 1 - CITIC Securities has received approval from the China Securities Regulatory Commission to issue perpetual subordinated bonds with a total face value of no more than 30 billion yuan [1] - The bonds can be issued in tranches within 24 months from the date of approval [1] Group 2 - Silan Microelectronics' shareholder, Luo Huabing, plans to reduce his holdings by no more than 500,000 shares, accounting for up to 0.03005% of the company's total share capital [2] - The reduction will occur within three months after a 15 trading day period from the announcement date [2] Group 3 - Sanofi Biologics' subsidiary has received a drug registration certificate for its injection product, which is a GLP-1 analog for improving blood sugar control in type 2 diabetes patients [3] - This certification enhances the company's product portfolio in the diabetes medication sector, positively impacting future performance [3] Group 4 - Lens Technology announced a global offering of H-shares with a base issuance of 262 million shares, with an initial price range set between 17.38 and 18.18 HKD [4] - The H-shares are expected to be listed on the Hong Kong Stock Exchange on July 9, 2025 [4] Group 5 - Huitian Ruisheng's controlling shareholder, He Lin, plans to reduce his holdings by up to 2.95% of the company's total shares, amounting to 177,740 shares [5] - Other executives also plan to reduce their holdings within a similar timeframe [5] Group 6 - Hongxin Electronics' subsidiaries signed contracts totaling 373 million yuan for AI-related services, indicating growth in the AI business sector [6] Group 7 - Hangzhou High-tech is planning a change in control, with the actual controller Hu Min intending to transfer 19.03% of the company's shares [7] - The stock is expected to be suspended for no more than two trading days [7] Group 8 - Junpu Intelligent signed a sales framework contract for humanoid robots worth approximately 28.25 million yuan [8] Group 9 - Alloy Investment announced a change in its controlling shareholder to Jiuzhou Hengchang, with stock resuming trading on July 1, 2025 [9] Group 10 - He Shi Eye Hospital's major shareholder plans to reduce holdings by up to 2% of the company's shares, totaling 310,610 shares [10] Group 11 - Prit's investment of 1 billion yuan in a new manufacturing base in Guangzhou is expected to produce 400,000 tons annually, focusing on non-automotive applications [11] Group 12 - Tongfu Microelectronics reported a 1% reduction in shares by the National Integrated Circuit Industry Investment Fund, decreasing its holding from 8.77% to 7.77% [12] Group 13 - Jinpu Titanium Industry plans to acquire the equity of Lide Dongfang through a major asset swap and cash payment, with stock suspension starting July 1, 2025 [13] Group 14 - Several companies have reported expected profit increases for the first half of the year, with notable growth percentages [16]

脑机接口行业点评 Neuralink 发布会公布三年计划，关注脑机接口进展 2025 年 06 月 30 日 ➢ 完成 E 轮融资加快研发，Neuralink 公布未来三年的发展计划。今年 6 月 上旬，Neuralink 宣布完成 6.5 亿美元的 E 轮融资，主要投资者包括方舟投资、 德丰杰成长基金、创始人基金、光速创投、红杉资本、兴盛资本等。发布会上 Neuralink 公布了未来的三年计划——2025 年第四季度：在言语皮层植入设备， 直接从大脑信号中解码有意识的词语，转换为语音。2026 年：将电极数量增加 到 3000 个，让首位「盲视」参与者重获视觉，初期是低分辨率导航，最终达到 超人多波段视觉。2027 年：增加通道数量至 10000 个，首次实现多设备植入 （运动皮层、言语皮层或视觉皮层）。2028 年：每个植入物达到超过 25000 个 通道，拥有多个植入物，能访问大脑的任何部分，治疗精神疾病、疼痛、失调， 并且与 AI 集成。马斯克宣称要在 2028 年实现将人类大脑与 AI 全面集成，实现 意识层面的互联。 ➢ 事件：6 月 28 日，马斯克召开 Neuralink 线上发布会，公布脑 ...

Core Insights - Neuralink is making steady progress in the brain-computer interface (BCI) sector, with its plans aligning with current industry trends and expectations [1][4] - The company aims to create a universal human brain input/output interface, with a long-term goal of achieving unprecedented bandwidth in neural activity communication [3][4] Group 1: Technological Developments - Neuralink has demonstrated that implanted devices allow users to control computers, play games, and operate robotic arms using brain signals [3] - The company plans to decode "intent language" directly from the speech cortex by the end of 2025 and expand the number of electrode channels to 3,000 by 2026 [4] - By 2028, Neuralink aims to increase the number of electrodes to 25,000, enabling comprehensive access to different brain regions for treating mental illnesses and exploring AI integration [4] Group 2: Industry Context - A technology expert from a Chinese BCI company noted that Neuralink's advancements and plans are valuable references for the industry, particularly in areas like motor function replacement and sensory restoration [4][5] - The expert emphasized that while the long-term goals of their company align with Neuralink's, their implementation strategies will be tailored to meet the specific needs of Chinese patients and market characteristics [5]

Market Overview - On June 30, A-shares experienced a volatile rise, with the ChiNext Index increasing by over 1% and more than 4,000 stocks rising. The trading volume was 1.52 trillion, down from 1.58 trillion the previous day [1] - The military industry stocks led the gains, with over ten stocks including Hengyu Xintong and Chenxi Aviation hitting the daily limit [1] - Gaming stocks also saw fluctuations, with companies like Giant Network and Kaiying Network reaching the daily limit [1] - The photovoltaic industry chain strengthened, particularly in the BC battery sector, with Guangxin Materials hitting the daily limit [1] - Stocks related to lithography machines were active, with companies like Blue Eagle Equipment and Kaimite Gas also hitting the daily limit [1] Banking and Securities Sector - Bank and brokerage stocks continued to adjust, with companies such as Qilu Bank and Zhengzhou Bank experiencing varying degrees of decline [2] Brain-Computer Interface (BCI) Sector - The brain-computer interface concept showed strong performance, with companies like Xiangyu Medical hitting the daily limit and Botao Bio rising over 8% [3] - Recent positive developments in the BCI sector have attracted global investor interest, with 2025 being highlighted as a critical year for BCI technology [4] - Neuralink, a company owned by Elon Musk, announced that seven individuals have implanted their N1 devices, allowing paralyzed individuals to control computers using their thoughts [5] - Neuralink's ambitious plans include a roadmap to develop a full-brain interface by 2028, enabling high-bandwidth connections between biological brains and external machines [7][9] Stock Performance and Market Reactions - The stock of Brain Regeneration Technology, a previously obscure company, surged by 13,192.24% this year after announcing FDA approval for its new neural modulation chip [11] - However, the stock price subsequently plummeted, leading to a loss of $33 billion in paper wealth, raising concerns among market observers [13] - Regulatory bodies may scrutinize the volatility in low-priced small-cap stocks, which are often susceptible to fraud [14] Future Prospects in BCI - The BCI market is expected to grow, with applications primarily in healthcare, and gradually expanding into education, gaming, and smart home sectors [14] - The development of higher precision sensors and lighter, more compatible devices is anticipated to enhance the BCI industry [14] - A list of BCI concept stocks shows several companies with strong institutional ratings and projected profit growth for 2025 and 2026, including Mindray Medical and Kailing Medical [16]

2025 年 06 月 30 日 马斯克公布脑机接口进展，Neuralink 估值快速 上升 推荐(维持) 事件 分析师：林子健 S1050523090001 linzj@cfsc.com.cn 行业相对表现 ▌Neuralink 展示新产品方向，有望链接生物大脑与 外部机器 | 表现 | 1M | 3M | 12M | | --- | --- | --- | --- | | 汽车(申万) | -0.4 | -3.0 | 30.0 | | 沪深 300 | 2.5 | 1.3 | 13.7 | 市场表现 -20 -10 0 10 20 30 40 50 (%) 汽车 沪深300 资料来源：Wind，华鑫证券研究 相关研究 1、《汽车行业点评报告：商务部开 展 2025 年千县万镇新能源汽车消费 季活动，政策加码新能源车下乡再 提速》2025-06-29 2、《汽车行业周报：Robotaxi 开启 试运营，人形机器人中长期信心不 改》2025-06-26 3、《汽车行业周报：人形机器人渠 道+应用场景加速落地，汽车供应链 迎来 60 天账期新变革》2025-06-16 当地时间 6 月 27 日，马斯克旗下脑机 ...

Core Viewpoint - The company, Jihua Group, clarifies that its main business and existing product system do not involve the brain-computer interface sector, despite being mistakenly associated with it by some media outlets [1] Group 1: Company Operations - Jihua Group's main business includes the research, production, and sales of workwear, work shoes, textile dyeing, and protective gear and equipment [1] - The company has confirmed that it has not engaged in any activities related to brain-computer interfaces as of now [1] Group 2: Stock Market Activity - The company's stock has experienced an abnormal fluctuation, with a cumulative price increase deviation of 20% over three consecutive trading days [1]

Core Viewpoint - The article discusses recent developments in the Chinese stock market, including the performance of various sectors and the implications of economic indicators such as PMI, as well as the potential for upcoming policy changes and international relations affecting market sentiment [1][2][5]. Economic Indicators - China's manufacturing and non-manufacturing PMI for June exceeded expectations, indicating stable growth momentum despite high tariffs from the US [2]. - Citi forecasts a strong actual growth rate of 5.3% for the first half of 2025, supported by a firm policy commitment to meet annual GDP targets [2]. - High-frequency tracking indicators show a rebound in China's exports to the US in June, suggesting continued monthly export growth [2]. Stock Market Performance - The Shanghai Composite Index rose by 2.76% in the first half of the year, while the North Star 50 Index surged by 39.45% [2]. - On a recent trading day, major indices collectively increased, with the Shanghai Composite up 0.59%, the Shenzhen Component up 0.83%, and the ChiNext Index up 1.35% [3]. Sector Highlights - The military industry sector saw significant gains, with multiple stocks hitting the daily limit up [3]. - Brain-computer interface concept stocks continued to perform well, driven by recent advancements announced by Neuralink [3]. - The photovoltaic sector experienced a surge, with domestic new photovoltaic installations reaching 92.92 GW in May, a year-on-year increase of 388.03% [3]. - The gaming sector exploded with 158 new games approved in June, marking a record high for the year, indicating a clear trend of regulatory easing [3]. Investment Strategies - Various institutions predict a bullish outlook for July, with policy support, liquidity easing, and positive mid-year earnings expectations driving the market [5][6]. - Recommended sectors for investment include technology, dividends, and military industries, with small-cap stocks expected to maintain relative advantages [5][6]. Fund Flows - The defense and military industry saw the largest net inflow of funds, with significant investments in leading companies [15]. - The overall market experienced a net inflow of 344.71 billion yuan, with notable interest in sectors such as defense, electric power equipment, and media [15][26]. Company Performance - TaoTao Automotive expects a net profit growth of 70%-98% year-on-year for the first half of the year [10]. - Hanyu Pharmaceutical anticipates a turnaround with a projected net profit of 142 million to 162 million yuan for the first half of 2025 [10]. Industry Developments - Major photovoltaic glass manufacturers plan to collectively reduce production by 30% starting in July to address oversupply issues [11]. - The Ministry of Commerce announced continued anti-dumping duties on imported stainless steel products from several countries, impacting market dynamics [12].

Core Viewpoint - The advent of brain-machine interface technology by Neuralink is poised to disrupt various industries, including education, healthcare, and the arts, leading to significant changes in job markets and societal structures [1][11]. Group 1: Impact on Healthcare - The technology has entered clinical trials, with 7 patients successfully implanted with Neuralink devices, allowing them to control computers and mechanical arms through thought [4]. - Disabled individuals, such as those with paralysis, can regain mobility through thought-controlled devices, potentially eliminating outdated medical equipment manufacturers [6]. - Vision restoration for the blind is possible through "blindsight" technology, which could drastically reduce the need for eye care professionals and related industries [7][8]. Group 2: Transformation of Education - Future students may download knowledge directly into their brains, drastically altering the educational landscape and potentially rendering traditional teaching methods obsolete [12][14]. - The rapid acquisition of knowledge could lead to a significant reduction in the demand for conventional educators, particularly those who rely on rote teaching methods [15]. Group 3: Effects on the Arts and Creative Industries - Artists may utilize brain signals to create music and art, which could enhance creativity but also threaten the livelihoods of traditional artists and designers [17]. - The integration of AI with brain-machine interfaces could lead to a scenario where everyone has access to vast knowledge, resulting in intense competition in creative fields [19]. Group 4: Market Potential and Growth - The brain-machine interface market in China is projected to reach $7.63 billion between 2025 and 2029, with a current industry scale of 2.8 billion yuan in 2024, reflecting a 20.1% growth [23][25]. - Regulatory frameworks are being established in China to support the development of brain-machine interfaces, including pricing guidelines for invasive and non-invasive procedures [27]. Group 5: Future Developments and Timeline - Neuralink has outlined a timeline for technological advancements, including the ability to decode speech from brain signals by late 2025 and achieving multi-device implants by 2028 [21][22]. - The rapid advancement of surgical robotics for electrode implantation is expected to enhance the feasibility of widespread brain-machine interface applications [22].